Table 2 Association between PLCD1 expression and clinicopathological parameters of KIRP patients in TCGA
Characteristic | Low expression of PLCD1 | High expression of PLCD1 | p value |
|---|---|---|---|
n | 144 | 145 | |
Pathologic T stage, n (%) | < 0.001 | ||
T1 | 79 (27.5%) | 114 (39.7%) | |
T2 | 18 (6.3%) | 15 (5.2%) | |
T3 | 45 (15.7%) | 14 (4.9%) | |
T4 | 1 (0.3%) | 1 (0.3%) | |
Pathologic N stage, n (%) | 0.041 | ||
N0 | 32 (41.6%) | 17 (22.1%) | |
N1 | 22 (28.6%) | 2 (2.6%) | |
N2 | 3 (3.9%) | 1 (1.3%) | |
Pathologic M stage, n (%) | 0.004 | ||
M0 | 49 (47.1%) | 46 (44.2%) | |
M1 | 9 (8.7%) | 0 (0%) | |
Age, median (IQR) | 61 (54, 69.25) | 62 (53, 73) | 0.268 |